MSB 7.43% $1.34 mesoblast limited

Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-115

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 15,657 Posts.
    lightbulb Created with Sketch. 5718

    Out in full force on the back of any positive Mesoblast news


    Just a reminder to everyone …. @DocMcstuffins argued with me for two years that the FDA would never entertain an Accelerated Approval pathway for CHF off the back of their amazing phase 3 trial results and yet here we are awaiting a Pre BLA Filing meeting for exactly that


    …. who to be wary of indeed … GLTAH
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.34
Change
0.093(7.43%)
Mkt cap ! $1.512B
Open High Low Value Volume
$1.27 $1.40 $1.27 $13.75M 10.23M

Buyers (Bids)

No. Vol. Price($)
9 38911 $1.34
 

Sellers (Offers)

Price($) Vol. No.
$1.35 73478 8
View Market Depth
Last trade - 14.49pm 03/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.